Legal & General Group PLC Emergent Bio Solutions Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.5 - $3.41 $3,346 - $7,607	-2,231 Reduced 33.75%	4,379 $11,000
Q4 2023 Feb 15, 2024	SELL	$1.82 - $3.16 $43,012 - $74,680	-23,633 Reduced 78.14%	6,610 $15,000
Q3 2023 Nov 14, 2023	SELL	$3.17 - $7.91 $758,888 - $1.89 Million	-239,397 Reduced 88.78%	30,243 $102,000
Q2 2023 Aug 14, 2023	SELL	$7.35 - $13.21 $116,504 - $209,391	-15,851 Reduced 5.55%	269,640 $1.98 Million
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $700,687 - $1.47 Million	89,947 Added 46.0%	285,491 $2.96 Million
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $166,331 - $324,345	15,121 Added 8.38%	195,544 $2.31 Million
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $483,365 - $861,347	24,060 Added 15.39%	180,423 $3.79 Million
Q2 2022 Aug 22, 2022	SELL	$27.42 - $43.63 $1.51 Million - $2.41 Million	-55,165 Reduced 26.08%	156,363 $4.85 Million
Q1 2022 May 16, 2022	BUY	$36.48 - $52.22 $157,630 - $225,642	4,321 Added 2.09%	211,528 $8.69 Million
Q4 2021 Feb 14, 2022	BUY	$33.11 - $55.01 $2.25 Million - $3.73 Million	67,883 Added 48.72%	207,207 $9.01 Million
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $1.15 Million - $1.51 Million	22,919 Added 19.69%	139,324 $6.98 Million
Q2 2021 Aug 12, 2021	BUY	$56.61 - $80.46 $259,556 - $368,909	4,585 Added 4.1%	116,405 $7.33 Million
Q1 2021 May 17, 2021	BUY	$86.23 - $125.19 $1.07 Million - $1.55 Million	12,367 Added 12.44%	111,820 $10.4 Million
Q4 2020 Feb 12, 2021	SELL	$79.17 - $111.47 $119,388 - $168,096	-1,508 Reduced 1.49%	99,453 $8.91 Million
Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $6.71 Million - $11.1 Million	-81,931 Reduced 44.8%	100,961 $10.4 Million
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $2.5 Million - $4.12 Million	46,044 Added 33.65%	182,892 $14.5 Million
Q1 2020 May 14, 2020	BUY	$49.34 - $68.76 $18,403 - $25,647	373 Added 0.27%	136,848 $7.9 Million
Q4 2019 Feb 13, 2020	BUY	$51.21 - $59.06 $616,619 - $711,141	12,041 Added 9.68%	136,475 $7.36 Million
Q3 2019 Nov 13, 2019	SELL	$40.6 - $57.2 $8,810 - $12,412	-217 Reduced 0.17%	124,434 $6.51 Million
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $16,447 - $22,190	412 Added 0.33%	124,651 $6.02 Million
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $906,868 - $1.24 Million	18,803 Added 17.83%	124,239 $6.28 Million
Q4 2018 Feb 15, 2019	BUY	$55.63 - $73.24 $94,404 - $124,288	1,697 Added 1.64%	105,436 $6.23 Million
Q3 2018 Nov 20, 2018	BUY	$52.05 - $66.51 $1.2 Million - $1.53 Million	22,982 Added 28.46%	103,739 $6.83 Million
Q2 2018 Aug 10, 2018	BUY	$48.33 - $55.64 $305,928 - $352,201	6,330 Added 8.5%	80,757 $4.09 Million
Q1 2018 May 17, 2018	BUY	$44.44 - $54.39 $134,253 - $164,312	3,021 Added 4.23%	74,427 $3.9 Million
Q4 2017 Feb 13, 2018	BUY	$37.77 - $47.75 $2.7 Million - $3.41 Million	71,406	71,406 $3.32 Million

Others Institutions Holding EBS

# of Institutions

157

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$41.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$36.9 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$27.1 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$24.2 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$20.8 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $542M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account